Change search
ReferencesLink to record
Permanent link

Direct link
Is the acetylcholine-regulated inwardly rectifying potassium current a viable antiarrhythmic target? Translational discrepancies of AZD2927 and A7071 in dogs and humans
Linköping University, Department of Medical and Health Sciences, Division of Cardiovascular Medicine. Linköping University, Faculty of Health Sciences. Region Östergötland, Heart and Medicine Center, Department of Cardiology in Linköping.ORCID iD: 0000-0003-3059-4404
Rikshospitalet, Oslo, Norway.
Astra Zeneca, CVMD Innovative Medicine, Mölndal, Sweden.
Astra Zeneca, CVMD Innovative Medicine, Mölndal, Sweden.
Show others and affiliations
2015 (English)In: Europace, ISSN 1099-5129, E-ISSN 1532-2092, Vol. 17, no 3, 473-482 p.Article in journal (Refereed) Published
Abstract [en]

AIMS: We aimed at examining the acetylcholine-dependent inward-rectifier current (IKAch) as a target for the management of atrial fibrillation (AF).

METHODS AND RESULTS: The investigative agents AZD2927 and A7071 concentration-dependently blocked IKACh in vitro with minimal off-target activity. In anaesthetized dogs (n = 17) subjected to 8 weeks of rapid atrial pacing (RAP), the left atrial effective refractory period (LAERP) was maximally increased by 50 ± 7.4 and 50 ± 4.8 ms following infusion of AZD2927 and A7071. Ventricular refractoriness and the QT interval were unaltered. During sustained AF, both drugs significantly reduced AF frequency and effectively restored sinus rhythm. AZD2927 successfully restored sinus rhythm at 10/10 conversion attempts and A7071 at 14/14 attempts, whereas saline converted 4/17 episodes only (P<0.001 vs. AZD2927 and A7071). In atrial flutter patients (n = 18) undergoing an invasive investigation, AZD2927 did not change LAERP, the paced QT interval, or ventricular refractoriness when compared with placebo. To address the discrepancy on LAERP by IKACh blockade in man and dog and the hypothesis that atrial electrical remodelling is a prerequisite for IKACh blockade being efficient, six dogs were studied after 8 weeks of RAP followed by sinus rhythm for 4 weeks to reverse electrical remodelling. In these dogs, both AZD2927 and A7071 were as effective in increasing LAERP as in the dogs studied immediately after the 8-week RAP period.

CONCLUSION: Based on the present series of experiments, an important role of IKACh in human atrial electrophysiology, as well as its potential as a viable target for effective management of AF, may be questioned.

Place, publisher, year, edition, pages
Oxford University Press, 2015. Vol. 17, no 3, 473-482 p.
Keyword [en]
Antiarrhythmic agents; Arrhythmia; Electrophysiology; Ion channels; Remodelling
National Category
Clinical Medicine
URN: urn:nbn:se:liu:diva-110995DOI: 10.1093/europace/euu192ISI: 000351605000024PubMedID: 25082948OAI: diva2:751846

This work was supported by AstraZeneca R&D, CVMD Innovative Medicine, Molndal, Sweden.

Available from: 2014-10-02 Created: 2014-10-02 Last updated: 2015-08-26

Open Access in DiVA

fulltext(399 kB)47 downloads
File information
File name FULLTEXT01.pdfFile size 399 kBChecksum SHA-512
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Walfridsson, Håkan
By organisation
Division of Cardiovascular MedicineFaculty of Health SciencesDepartment of Cardiology in Linköping
In the same journal
Clinical Medicine

Search outside of DiVA

GoogleGoogle Scholar
Total: 47 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 121 hits
ReferencesLink to record
Permanent link

Direct link